Differences between rheumatoid arthritis and osteoarthritis

Written by: Dr Stephanie Kaye-Barrett
Published:
Edited by: Top Doctors®

Osteoarthritis and rheumatoid arthritis, both well-known conditions, come under the umbrella term ‘arthritis’. But what’s the difference? After reading this article by Dr Stephanie Kaye-Barrett, a leading consultant rheumatologist with over 17 years’ experience, you’ll understand the key differences.

 

Office habits are a known cause of both issues.

 

What are they?

Rheumatoid arthritis (RA) is an autoimmune condition in which the body produces antibodies against itself. The target tissue is the synovial membrane, which is the inner lining of the joints.

 

Osteoarthritis (OA), on the other hand, is a degenerative wear and tear condition. The surface cartilage of the joints is worn away from use and this eventually leads to bone touching bone. This results in severe pain.

 

Treatment of RA

Disease-modifying agents are used to treat rheumatoid arthritis, such as methotrexate, sulphasalazine and hydroxychloroquine. Steroid injections into joints or directly into the muscle are very useful in the early stages to achieve control of inflammation. The ‘game changers’ for RA are the biological treatments such as adalimumab (Humira) and etanercept. There are many more drugs and such a wide variety of choice. The aim is to achieve control of the inflammatory response, which in turn treats the pain and incapacity.

 

The key to success is early detection and diagnosis of RA. Blood should be measured for:

  • CRP (a test marker for inflammation)
  • ESR (reveals inflammatory activity)
  • rheumatoid factors (proteins produced by the immune system)
  • anti-CCP antibodies (these are present in most patients with RA)

The blood test should be followed by an ultrasound of the affected joints which demonstrates the synovitis (inflammation of the synovial membrane) and inflammation, accurately. These tests may be requested by a general practitioner but the diagnosis and management must be made by a specialised consultant rheumatologist.

 

Treatment of OA

Unlike rheumatoid arthritis, there are no specific drug treatments for osteoarthritis: it can’t be halted with appropriate medication. The main focus is to reduce the weight that is forced on weight-bearing joints such as the knees, hips, feet and ankles. Injections can be helpful in regards to pain control.

 

Outlook of RA

The outlook for rheumatoid arthritis is very positive when diagnosed and treated early. Patients must be referred to a consultant rheumatologist, without delay, to achieve relief for their symptoms through the most up to date and appropriate medications.

 

Outlook of OA

Many patients with osteoarthritis will ultimately need to be referred for joint replacement surgery despite previous treatments. However, physiotherapy is extremely helpful to build muscle and support for the damaged joints.

 

Which is worse?

Neither condition is worse than the other: they are simply different.

 

Can an X-ray differentiate between osteoarthritis and rheumatoid arthritis?

In some cases. Osteoarthritis is diagnosed with an X-ray whereas rheumatoid arthritis is best diagnosed with an ultrasound because it can detect synovitis (inflammation of the synovial membrane) and joint swelling. Rheumatoid arthritis can be diagnosed with an X-ray but usually, bony erosions from rheumatoid arthritis only appear at a later stage of the condition.

 

Can other autoimmune diseases mimic rheumatoid arthritis?

Yes, but blood tests are used to help differentiate rheumatoid arthritis with other autoimmune diseases. 

 

What’s the best way to treat both types of arthritis?

Immune modulating drugs are best for rheumatoid arthritis. Osteoarthritis requires physio, joint injections and surgery.

 

Both conditions are supported by physio and patients can benefit greatly from its ability to aid muscle strength and reduce pain. It’s important to remember that physio is not curative, however.

 

If you’d like to learn more about these conditions or receive specialist treatment, get in touch with Dr Kaye-Barrett by visiting her profile.

By Dr Stephanie Kaye-Barrett
Rheumatology

Dr Stephanie Kaye-Barrett is one of central London's leading rheumatologists, with over 20 years of consultant-grade experience. She specialises in injectable and osteoporosis treatment and the resolution of painful musculoskeletal conditions including gout, fibromyalgia syndrome (FMS), arthritis, and rheumatoid arthritis, alongside hypermobility and inflammatory joint diseases.

She is the founder of RTMS London at The London Clinic, the first rheumatology clinic in the UK to offer the repetitive transcranial magnetic stimulation (rTMS) brain stimulation technique for fibromyalgia and chronic musculoskeletal pain. RTMS is a treatment method that requires no medication and is recommended by the National Institute for Care and Health Excellence (NICE) for depression. the safety record of TMS has been well-established over many years of use. Dr Barrett introduced this to treat non-inflammatory musculoskeletal pain that has not responded to usual modalities. Studies have also found that a course of rTMS treatments has been found to reduce pain symptoms in many patients with fibromyalgia. 

Furthermore, Dr Kaye-Barrett, who also treats lateral hip pain/trochanteric bursitis, shoulder pain, tennis elbow, and plantar fascitis, leads 'one-stop' rheumatology services at her clinics, where she advises on prevention, detection, and treatment of musculoskeletal pain and fibromyalgia. Additionally, she is a specialist in new biological therapies for the treatment of rheumatoid arthritis and persistent inflammatory arthritis of the knee, in particular.

Due to her exemplary work, Dr Kaye-Barrett has been featured on BBC's series called "The Diagnosis Detectives", where leading experts in the UK diagnose patients with puzzling symptoms. 

Dr Kaye-Barrett initially qualified from Liverpool University School of Medicine, winning the final year clinical medical prize. She won the Graham White scholarship and Roaf Travelling scholarship to pursue specialist training abroad before receiving the Junior Clinical Fellowship from Arthritis Research UK. Her research subsequently led to her completing an MD at the Royal Free Hospital.

Among her many roles in public associations, Dr Kaye-Barrett was elected President of the Royal Society of Medicine, Rheumatology Division, in 2017 where she is now a trustee and member of council. She is highly involved in her field via both research, and the education of future rheumatologists. Her research focuses included osteoporosis, vitamin D deficiency, gout, and early identification of rheumatoid arthritis. Dr Kaye-Barrett lectures nationally and internationally, and she underwent training as an appraiser for the Independent Doctors Federation (IDF). Furthermore, Dr Kaye-Barrett has been featured in all published Tatler's 250 Top Doctors Guides.

Currently, Dr Kaye-Barrett is working with the Royal Society of Medicine to provide medical education in live webinars and interviews regarding COVID-19 and the Cytokine Storm, as well as other autoimmune and auto inflammatory topics in relation to COVID-19. These live interviews and webinars were broadcast to 22 countries around the globe.

View Profile

Overall assessment of their patients


  • Related procedures
  • Botulinum toxin (Botox™)
    Facial paralysis
    Erectile dysfunction
    Urinary incontinence
    Pelvic pain
    Neuropathic pain
    Epilepsy
    Consciousness disorders
    Restless legs syndrome
    Neurological disorders
    This website uses our own and third-party Cookies to compile information with the aim of improving our services, to show you advertising related to your preferences as well analysing your browsing habits. You can change your settings HERE.